Epic Sciences is working on cancer detection through blood tests, which detect circulating tumor cells. The tests are especially helpful in detecting cancers in areas that are more difficult to biopsy such as the lungs.

Epic Sciences is working on cancer detection through blood tests, which detect circulating tumor cells. The tests are especially helpful in detecting cancers in areas that are more difficult to biopsy such as the lungs.

EPIC SCIENCES

CEO: David Nelson.

Revenue: Not disclosed.

No. of local employees: 25.

Investors: Domain Associates, Roche Venture Fund, Pfizer Venture Investments, and others.

Headquarters: Torrey Pines Mesa.

Year founded: 2008.

Company description: Epic is developing highly sensitive diagnostic tests that reveal circulating tumor cells (CTCs) in the blood to provide a better and faster way to detect cancer and to monitor and personalize cancer treatments.

Key factors for success: Breakthrough science and technology for an important medical need; collaborative pharma partnerships that have advanced the technology into clinical trials; having the support of experienced investors.

Even in a challenging economic climate, San Diego startup Epic Sciences has been able to access private, venture capital and government financing to advance its work in developing diagnostics that could be used to detect and guide treatments for many types of cancer...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129